{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:42:28Z","timestamp":1789926148186,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG002132"],"award-info":[{"award-number":["AG002132"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG031220"],"award-info":[{"award-number":["AG031220"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council of Australia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00401-017-1762-2","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T07:38:36Z","timestamp":1503905916000},"page":"49-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["MSA prions exhibit remarkable stability and resistance to inactivation"],"prefix":"10.1007","volume":"135","author":[{"given":"Amanda L.","family":"Woerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeen A.","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Freyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Mordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefkos T.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Gentleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley B.","family":"Prusiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"key":"1762_CR1","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.neubiorev.2012.06.001","volume":"36","author":"RJ Anderson","year":"2012","unstructured":"Anderson RJ, Frye MA, Abulseoud OA, Lee KH, McGillivray JA, Berk M, Tye SJ (2012) Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev 36:1920\u20131933","journal-title":"Neurosci Biobehav Rev"},{"key":"1762_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/JVI.77.1.583-591.2003","volume":"77","author":"JC Bartz","year":"2003","unstructured":"Bartz JC, Kincaid AE, Bessen RA (2003) Rapid prion neuroinvasion following tongue infection. J Virol 77:583\u2013591","journal-title":"J Virol"},{"key":"1762_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(77)91958-4","volume":"309","author":"C Bernoulli","year":"1977","unstructured":"Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, Gibbs CJ Jr (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 309:478\u2013479","journal-title":"Lancet"},{"key":"1762_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/JPD-150691","volume":"6","author":"L Bousset","year":"2016","unstructured":"Bousset L, Brundin P, B\u00f6ckmann A, Meier B, Melki R (2016) An efficient procedure for removal and inactivation of alpha-synuclein assemblies from laboratory materials. J Parkinsons Dis 6:143\u2013151","journal-title":"J Parkinsons Dis"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, B\u00f6ckmann A, Meier BH et al (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575","journal-title":"Nat Commun"},{"key":"1762_CR6","doi-asserted-by":"publisher","first-page":"9182","DOI":"10.1128\/JVI.01399-16","volume":"90","author":"S Breid","year":"2016","unstructured":"Breid S, Bernis ME, Babila JT, Garza MC, Wille H, Tamg\u00fcney G (2016) Neuroinvasion of \u03b1-synuclein prionoids after intraperitoneal and intraglossal inoculation. J Virol 90:9182\u20139193","journal-title":"J Virol"},{"key":"1762_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0092-8674(86)90875-5","volume":"46","author":"GA Carlson","year":"1986","unstructured":"Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S, Westaway D, Prusiner SB (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503\u2013511","journal-title":"Cell"},{"key":"1762_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-013-1231-5","volume":"127","author":"F Clavaguera","year":"2014","unstructured":"Clavaguera F, Hench J, Lavenir I, Schweighauser G, Frank S, Goedert M, Tolnay M (2014) Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol 127:299\u2013301","journal-title":"Acta Neuropathol"},{"key":"1762_CR9","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.biopsych.2016.03.1049","volume":"80","author":"I Corripio","year":"2016","unstructured":"Corripio I, Sarr\u00f3 S, McKenna PJ, Molet J, \u00c1lvarez E, Pomarol-Clotet E, Portella MJ (2016) Clinical improvement in a treatment-resistant patient with schizophrenia treated with deep brain stimulation. Biol Psychiatry 80:e69\u2013e70","journal-title":"Biol Psychiatry"},{"key":"1762_CR10","doi-asserted-by":"publisher","DOI":"10.3171\/2016.10.JNS161573","author":"RS Dowd","year":"2017","unstructured":"Dowd RS, Pourfar M, Mogilner AY (2017) Deep brain stimulation for Tourette syndrome: a single-center series. J Neurosurg. doi: \n                    10.3171\/2016.10.JNS161573","journal-title":"J Neurosurg"},{"key":"1762_CR11","doi-asserted-by":"publisher","first-page":"12926","DOI":"10.1073\/pnas.0903200106","volume":"106","author":"YS Eisele","year":"2009","unstructured":"Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, Roth K, Aguzzi A, Staufenbiel M, Walker LC et al (2009) Induction of cerebral \u03b2-amyloidosis: intracerebral versus systemic A\u03b2 inoculation. Proc Natl Acad Sci USA 106:12926\u201312931","journal-title":"Proc Natl Acad Sci USA"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M (2010) Peripherally applied A\u03b2-containing inoculates induce cerebral \u03b2-amyloidosis. Science 330:980\u2013982","journal-title":"Science"},{"key":"1762_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372:249\u2013263","journal-title":"N Engl J Med"},{"key":"1762_CR14","doi-asserted-by":"publisher","first-page":"e0167875","DOI":"10.1371\/journal.pone.0167875","volume":"11","author":"SM Fayad","year":"2016","unstructured":"Fayad SM, Guzick AG, Reid AM, Mason DM, Bertone A, Foote KD, Okun MS, Goodman WK, Ward HE (2016) Six-nine year follow-up of deep brain stimulation for obsessive-compulsive disorder. PLoS One 11:e0167875","journal-title":"PLoS One"},{"key":"1762_CR15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF03401958","volume":"7","author":"E Flechsig","year":"2001","unstructured":"Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C (2001) Transmission of scrapie by steel-surface-bound prions. Mol Med 7:679\u2013684","journal-title":"Mol Med"},{"key":"1762_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-014-1339-2","volume":"128","author":"SK Fritschi","year":"2014","unstructured":"Fritschi SK, Cintron A, Ye L, Mahler J, B\u00fchler A, Baumann F, Neumann M, Nilsson KPR, Hammarstr\u00f6m P, Walker LC et al (2014) A\u03b2 seeds resist inactivation by formaldehyde. Acta Neuropathol 128:477\u2013484","journal-title":"Acta Neuropathol"},{"key":"1762_CR17","first-page":"w14287","volume":"146","author":"K Frontzek","year":"2016","unstructured":"Frontzek K, Lutz MI, Aguzzi A, Kovacs GG, Budka H (2016) Amyloid-\u03b2 pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. Swiss Med Wkly 146:w14287","journal-title":"Swiss Med Wkly"},{"key":"1762_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/mds.20678","volume":"21","author":"F Geser","year":"2006","unstructured":"Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba J-P, Ulmer H, Pellecchia MT et al (2006) Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 21:179\u2013186","journal-title":"Mov Disord"},{"key":"1762_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"1762_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp.57.6.757","volume":"57","author":"CJ Gibbs Jr","year":"1994","unstructured":"Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC (1994) Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 57:757\u2013758","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1762_CR21","volume-title":"Prion biology","author":"K Giles","year":"2017","unstructured":"Giles K, Woerman AL, Berry DB, Prusiner SB (2017) Bioassays and inactivation of prions. In: Prusiner SB (ed) Prion biology. Cold Spring Harbor Laboratory Press, New York"},{"key":"1762_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, D\u00fcrr A, Fowler CJ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"1762_CR23","first-page":"516","volume":"58","author":"WS Gordon","year":"1946","unstructured":"Gordon WS (1946) Advances in veterinary research. Vet Rec 58:516\u2013520","journal-title":"Vet Rec"},{"key":"1762_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","volume":"125","author":"AJ Hughes","year":"2002","unstructured":"Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861\u2013870","journal-title":"Brain"},{"key":"1762_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature15369","volume":"525","author":"Z Jaunmuktane","year":"2015","unstructured":"Jaunmuktane Z, Mead S, Ellis M, Wadsworth JDF, Nicoll AJ, Kenny J, Launchbury F, Linehan J, Richard-Loendt A, Walker AS et al (2015) Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy. Nature 525:247\u2013250","journal-title":"Nature"},{"key":"1762_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1099\/0022-1317-67-2-255","volume":"67","author":"RH Kimberlin","year":"1986","unstructured":"Kimberlin RH, Walker CA (1986) Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 67:255\u2013263","journal-title":"J Gen Virol"},{"key":"1762_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85:404\u2013412","journal-title":"Neurology"},{"key":"1762_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00401-016-1565-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Lutz MI, Ricken G, Str\u00f6bel T, H\u00f6ftberger R, Preusser M, Regelsberger G, H\u00f6nigschnabl S, Reiner A, Fischer P et al (2016) Dura mater is a potential source of A\u03b2 seeds. Acta Neuropathol 131:911\u2013923","journal-title":"Acta Neuropathol"},{"key":"1762_CR29","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/00001756-200107200-00009","volume":"12","author":"E Kuusisto","year":"2001","unstructured":"Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. NeuroReport 12:2085\u20132090","journal-title":"NeuroReport"},{"key":"1762_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1756-0500-3-60","volume":"3","author":"SE Lakhan","year":"2010","unstructured":"Lakhan SE, Callaway E (2010) Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review. BMC Res Notes 3:60","journal-title":"BMC Res Notes"},{"key":"1762_CR31","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/cb5006239","volume":"10","author":"DJ Levine","year":"2015","unstructured":"Levine DJ, St\u00f6hr J, Falese LE, Ollesch J, Wille H, Prusiner SB, Long JR (2015) Mechanism of scrapie prion precipitation with phosphotungstate anions. ACS Chem Biol 10:1269\u20131277","journal-title":"ACS Chem Biol"},{"key":"1762_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/path.1711550105","volume":"155","author":"J Lowe","year":"1988","unstructured":"Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson\u2019s disease, Pick\u2019s disease, and Alzheimer\u2019s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 155:9\u201315","journal-title":"J Pathol"},{"key":"1762_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136:1128\u20131138","journal-title":"Brain"},{"key":"1762_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.parkreldis.2016.01.005","volume":"24","author":"WG Meissner","year":"2016","unstructured":"Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto J-L, Tison F, Eusebio A et al (2016) Outcome of deep brain stimulation in slowly progressive multiple system atrophy: a clinico-pathological series and review of the literature. Parkinsonism Relat Disord 24:69\u201375","journal-title":"Parkinsonism Relat Disord"},{"key":"1762_CR35","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1212\/01.WNL.0000028690.15001.00","volume":"59","author":"Y Osaki","year":"2002","unstructured":"Osaki Y, Ben-Shlomo Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, Quinn N (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59:1486\u20131491","journal-title":"Neurology"},{"key":"1762_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79\u2013100","journal-title":"J Neurol Sci"},{"key":"1762_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"1762_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1128\/JVI.80.1.322-331.2006","volume":"80","author":"D Peretz","year":"2006","unstructured":"Peretz D, Supattapone S, Giles K, Vergara J, Freyman Y, Lessard P, Safar JG, Glidden DV, McCulloch C, Nguyen H-OB et al (2006) Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 80:322\u2013331","journal-title":"J Virol"},{"key":"1762_CR39","first-page":"193","volume":"136","author":"M Poisson","year":"1980","unstructured":"Poisson M, Magdelenat H, Foncin JF, Bleibel JM, Philippon J, Pertuiset B, Buge A (1980) R\u00e9cepteurs d\u2019cestrog\u00e9nes et de progest\u00e9rone dans les m\u00e9ningiomes. Rev Neurol (Paris) 136:193\u2013203","journal-title":"Rev Neurol (Paris)"},{"key":"1762_CR40","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Rampersaud R, Watts JC, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with signs of Parkinson\u2019s disease. Proc Natl Acad Sci USA 112:E5308\u2013E5317","journal-title":"Proc Natl Acad Sci USA"},{"key":"1762_CR41","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR et al (2014) Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci USA 111:10732\u201310737","journal-title":"Proc Natl Acad Sci USA"},{"key":"1762_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/2654","volume":"4","author":"J Safar","year":"1998","unstructured":"Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4:1157\u20131165","journal-title":"Nat Med"},{"key":"1762_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00401-014-1360-5","volume":"129","author":"M Schweighauser","year":"2015","unstructured":"Schweighauser M, Bacioglu M, Fritschi SK, Shimshek DR, Kahle PJ, Eisele YS, Jucker M (2015) Formaldehyde-fixed brain tissue from spontaneously ill \u03b1-synuclein transgenic mice induces fatal \u03b1-synucleinopathy in transgenic hosts. Acta Neuropathol 129:157\u2013159","journal-title":"Acta Neuropathol"},{"key":"1762_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208","journal-title":"Neurosci Lett"},{"key":"1762_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","volume":"8","author":"N Stefanova","year":"2009","unstructured":"Stefanova N, B\u00fccke P, Duerr S, Wenning GK (2009) Multiple system atrophy: an update. Lancet Neurol 8:1172\u20131178","journal-title":"Lancet Neurol"},{"key":"1762_CR46","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/S0195-6701(99)90067-1","volume":"43","author":"DM Taylor","year":"1999","unstructured":"Taylor DM (1999) Inactivation of prions by physical and chemical means. J Hosp Infect 43:S69\u2013S76","journal-title":"J Hosp Infect"},{"key":"1762_CR47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/sj.embor.embor827","volume":"4","author":"A Thomzig","year":"2003","unstructured":"Thomzig A, Kratzel C, Lenz G, Kruger D, Beekes M (2003) Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 4:530\u2013533","journal-title":"EMBO Rep"},{"key":"1762_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40478-014-0151-5","volume":"2","author":"A Thomzig","year":"2014","unstructured":"Thomzig A, Wagenf\u00fchr K, Daus ML, Joncic M, Schulz-Schaeffer WJ, Thanheiser M, Mielke M, Beekes M (2014) Decontamination of medical devices from pathological amyloid-\u03b2-, tau- and \u03b1-synuclein aggregates. Acta Neuropathol Commun 2:151","journal-title":"Acta Neuropathol Commun"},{"key":"1762_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410440324","volume":"44","author":"PH Tu","year":"1998","unstructured":"Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble \u03b1-synuclein. Ann Neurol 44:415\u2013422","journal-title":"Ann Neurol"},{"key":"1762_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) \u03b1-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180\u2013182","journal-title":"Neurosci Lett"},{"key":"1762_CR51","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci USA 110:19555\u201319560","journal-title":"Proc Natl Acad Sci USA"},{"key":"1762_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"GK Wenning","year":"1997","unstructured":"Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133\u2013147","journal-title":"Mov Disord"},{"key":"1762_CR53","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","volume":"112","author":"AL Woerman","year":"2015","unstructured":"Woerman AL, St\u00f6hr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC, Ohyama T, Patel S, Widjaja K, Oehler A et al (2015) Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci USA 112:E4949\u2013E4958","journal-title":"Proc Natl Acad Sci USA"},{"key":"1762_CR54","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1086\/502392","volume":"25","author":"ZX Yan","year":"2004","unstructured":"Yan ZX, Stitz L, Heeg P, Pfaff E, Roth K (2004) Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 25:280\u2013283","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1762_CR55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03402121","volume":"5","author":"E Zobeley","year":"1999","unstructured":"Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C (1999) Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5:240\u2013243","journal-title":"Mol Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1762-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:48:19Z","timestamp":1589618899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1762-2","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,28]]},"assertion":[{"value":"11 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Institute for Neurodegenerative Diseases has a research collaboration with Daiichi Sankyo (Tokyo, Japan). SBP is the chair of the Scientific Advisory Board of Alzheon, Inc., which has not contributed financial or any other support to these studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animals were maintained in an AAALAC-accredited facility in compliance with the Guide for the Care and Use of Laboratory Animals. All procedures used in this study were approved by the University of California, San Francisco, Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This work was supported by grants from the National Institutes of Health (AG002132 and AG031220), as well as by gifts from the Glenn Foundation, Daiichi Sankyo, the Dana Foundation, the Henry M. Jackson Foundation, the Mary Jane Brinton Fund, the Rainwater Charitable Foundation, the Schott Foundation for Public Education, and the Sherman Fairchild Foundation. The Massachusetts Alzheimer\u2019s Disease Research Center is supported by the National Institutes of Health (AG005134); the Parkinson\u2019s UK Brain Bank at Imperial College London is funded by Parkinson\u2019s UK, a charity registered in England and Wales (948776) and in Scotland (SC037554); and the Sydney Brain Bank is supported by Neuroscience Research Australia and the University of New South Wales. Glenda\u00a0M. Halliday is a National Health and Medical Research Council of Australia Senior Principal Research Fellow (1079679).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}